Exelixis (EXEL) Tops Q4 EPS by 17c, provides guidance
Exelixis (NASDAQ: EXEL) reported Q4 EPS of $0.97, $0.17 better than the analyst estimate of $0.80. Revenue for the quarter came in at $598.66 million versus the consensus estimate of $604.56 million.
GUIDANCE:
Exelixis sees FY2026 revenue of $2.525-2.625 billion, versus the consensus of $2.596 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
